A pilot study of combining rituximab and low-dose (1.0Gy) total nodal irradiation in treatment of extensive chronic graft-versus-host disease
Phase of Trial: Phase II
Latest Information Update: 22 Jun 2016
At a glance
- Drugs Rituximab (Primary)
- Indications Graft-versus-host disease
- Focus Adverse reactions
- 08 Jun 2016 Status changed from recruiting to completed.
- 19 Jan 2009 New trial record.